Skip to main content
SpringerLink
Log in

Bronchodilators: Basic Pharmacology

  • Chapter
Chronic Obstructive Pulmonary Disease

Abstract

Bronchodilators are widely used in the therapy of COPD and provide modest relief of symptoms and increase the exercise tolerance. The pharmacology of bronchodilators is largely concerned with the relaxation of airway smooth muscle, although it is increasingly recognized that bronchodilators may also affect other cell types. This chapter discusses the molecular, biochemical and clinical pharmacology of bronchodilators currently used in the treatment of COPD and also describes some novel bronchodilators under development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Löfdahl, C.G. and Chung, K.F. (1991) Long-acting β2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur. Resp. J., 4, 218–26.

    Google Scholar 

  2. Barnes, P.J. (1992) β-Receptors on airway smooth muscle, nerves and inflammatory cells. Life Sci., 52, 2101–9.

    Google Scholar 

  3. Barnes, P.J., Basbaum, C.B., Nadel, J.A. and Roberts, J.M. (1982) Localization of β-adrenoceptors in mammalian lung by light microscopic autoradiography. Nature, 299, 444–7.

    PubMed  CAS  Google Scholar 

  4. Carstairs, J.R., Nimmo, A.J. and Barnes, P.J. (1984) Autoradiographic localisation of beta-adrenoceptors in human lung. Eur. J. Pharmacol., 103, 189–90.

    PubMed  CAS  Google Scholar 

  5. Barnes, P.J., Nadel, J.A., Skoogh, B-E. and Roberts, J.M. (1983) Characterization of beta-adrenoceptor subtypes in canine airway smooth muscle by radioligand binding and physiological responses. J. Pharmacol. Exp. Ther., 225, 456–61.

    PubMed  CAS  Google Scholar 

  6. Carstairs, J.R., Nimmo, A.J. and Barnes, P.J. (1985) Autoradiographic visualization of β-adrenoceptor subtypes in human lung. Am. Rev. Respir. Dis., 132, 541–7.

    PubMed  CAS  Google Scholar 

  7. Hamid, Q.A., Mak, J.C., Sheppard, M.N. et al. (1991) Localization of β2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography. Eur. J. Pharmacol., 206, 133–8.

    PubMed  CAS  Google Scholar 

  8. Nijkamp, F.P., Engels, F., Henricks, P.A.J. and van Oosterhout, A.J.M. (1992) Mechanisms of β-adrenergic receptor regulation in lung and its implication for physiological responses. Physiol. Rev., 72, 323–67.

    PubMed  CAS  Google Scholar 

  9. Giembycz, M.A. and Raeburn, D. (1991) Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J. Autonomic Pharmacol., 166, 365–98.

    Google Scholar 

  10. Gerthoffer, U.T. (1986) Calcium dependence of myosin phosphorylation and airway smooth muscle contraction and relaxation. Am. J. Physiol., 250, C597–604.

    PubMed  CAS  Google Scholar 

  11. Hall, I.P. and Hill, S.J. (1988) Beta2-adrenoceptor stimulation inhibits histamine stimulated inositol phospholipid hydrolysis in bovine tracheal smooth muscle. Br. J. Pharmacol., 95, 1204–12.

    PubMed  CAS  Google Scholar 

  12. Twort, C.A.C. and van Breemen, C. (1989) Human airway smooth muscle in cell culture: control of the intracellular calcium store. Pulm. Pharmacol., 2, 45–53.

    PubMed  CAS  Google Scholar 

  13. Gunst, S.J. and Stropp, J.Q. (1988) Effect of Na-K adenosine triphosphatase activity on relaxation of canine tracheal smooth muscle. J. Appl. Physiol., 64, 635–41.

    PubMed  CAS  Google Scholar 

  14. Jones, T.R., Charette, L., Garcia, M.L. and Kaczorowski, G.J. (1990) Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca++-activated K+ channel inhibitor. J. Pharmacol. Exp. Ther, 225, 697–706.

    Google Scholar 

  15. Jones, T.R., Charette, L., Garcia, M.L. and Kaczorowski, G.J. (1993) Interaction of iberiotoxin with β-adrenoceptor agonists and sodium nitroprosside on guinea pig trachea. J. Appl. Physiol., 74, 1879–84.

    PubMed  CAS  Google Scholar 

  16. Miura, M., Belvisi, M.G., Stretton, C.D. et al. (1992) Role of potassium channels in bronchodilator responses in human airways. Am. Rev. Respir. Dis., 146, 132–6.

    PubMed  CAS  Google Scholar 

  17. Kume, H., Takai, A., Tokuno, H., and Tomita, T. (1989) Regulation of Ca2+-dependent K+-channel activity in tracheal myocytes by phosphorylation. Nature, 341, 152–4.

    PubMed  CAS  Google Scholar 

  18. Kume, H., Hall, I.P., Washabau, R.J. et al. (1994) β-Adrenergic agents regulate KCa channels in airway smooth muscle by CAMP-dependent and-independent mechanisms. J. Clin. Invest., 93, 371–9.

    PubMed  CAS  Google Scholar 

  19. Waldeck, B. and Widmark, E. (1985) Comparison of the effects of forskolin and isoprenaline on tracheal, cardiac and skeletal muscles from guinea-pig. Eur. J. Pharmacol., 112, 349–53.

    PubMed  CAS  Google Scholar 

  20. Barnes, P.J. (1992) Modulation of neurotransmission in airways. Physiol. Rev., 72, 699–729.

    PubMed  CAS  Google Scholar 

  21. Danser, A.H.J., van den Ende, R., Lorenz, R.R. et al. (1987) Prejunctional β1-adrenoceptors inhibit cholinergic neurotransmission in canine bronchi. J. Appl. Physiol., 62, 785–90.

    PubMed  CAS  Google Scholar 

  22. Janssen, L.J. and Daniel, E.E. (1991) Characterization of the prejunctional β-adrenoceptors in canine bronchial smooth muscle. J. Pharmacol. Exp. Ther., 254, 741–9.

    Google Scholar 

  23. Skoogh, B-E. and Svedmyr, N. (1989) β2-Adrenoceptor stimulation inhibits ganglionic transmission in ferret trachea. Pulm. Pharmacol., 1, 167–72.

    PubMed  CAS  Google Scholar 

  24. Rhoden, K.J., Meldrum, L.A. and Barnes, P.J. (1988) Inhibition of cholinergic neurotransmission in human airways by β2-adrenoceptors. J. Appl. Physiol., 26, 65–72.

    Google Scholar 

  25. Aizawa, H., Inoue, H., Miyazaki, N. et al. (1991) Effects of procaterol, a beta2-adrenoceptor stimulant, on neuroeffector transmission in human bronchial tissue. Respiration, 58, 163–6.

    PubMed  CAS  Google Scholar 

  26. Daniel, E.E., Kannan, M., Davis, C. and Posey-Daniel, V. (1986) Ultrastructural studies on the neuromuscular control of human tracheal and bronchial muscle. Respir. Physiol., 63, 109–28.

    PubMed  CAS  Google Scholar 

  27. Verleden, G.M., Belvisi, M.G., Rabe, K.F. et al. (1993) β2-Adrenoceptors inhibit NANC neural bronchoconstrictor responses in vitro. J. Appl. Physiol., 74, 1195–9.

    PubMed  CAS  Google Scholar 

  28. Itabashi, S., Aikawa, T., Sekizawa, K. et al. (1992). Evidence that an atypical β-adrenoceptor mediates the prejunctional inhibition of non-adrenergic non-cholinergic contraction in guinea pig bronchi. Eur. J. Pharmacol., 218, 187–90.

    PubMed  CAS  Google Scholar 

  29. Nichol, G., Nix, A., Barnes, P.J. and Chung, K.F. (1990) Prostaglandin F2α enhancement of capsaicin induced cough in man: modulation by β2-adrenergic and anticholinergic drugs. Thorax, 45, 694–8.

    PubMed  CAS  Google Scholar 

  30. O’Connor, B.J., Ridge, S.M., Barnes, P.J. and Fuller, R.W. (1992) Comparative effect of terbutaline on mast cell and neurally mediated bronchoconstriction in asthma. Thorax, 46, 745P.

    Google Scholar 

  31. Maguire, W.C. and Nair, S. (1978) Ventilation and perfusion effects of inhaled alpha and beta agonists in asthma patients. Chest, 73 (Suppl), 983–5.

    PubMed  CAS  Google Scholar 

  32. Erjefält, I. and Persson, C.G.A. (1986) Anti-asthma drugs attenuate inflammatory leakage into airway lumen. Acta Physiol. Scand., 128, 653–5.

    PubMed  Google Scholar 

  33. Tokuyama, K., Lötvall, J.O., Löfdahl, C.-G. et al. (1991) Inhaled formoterol inhibits histamine induced airflow obstruction and airway microvascular leakage. Eur. J. Pharmacol. Sci., 193, 35–40.

    CAS  Google Scholar 

  34. Barnes, P.J. and Chung, K.F. (1992) Questions about inhaled β2-agonists in asthma. Trends Pharmacol. Sci, 13, 20–3.

    PubMed  CAS  Google Scholar 

  35. Laitinen, L.A., Laitinen, A., and Haahtela, T. (1992) A comparative study of the effects of an inhaled corticosteroid, budesonide, and of a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J. Allergy Clin. Immunol., 90, 32–42.

    PubMed  CAS  Google Scholar 

  36. Roberts, J.A., Bradding, P., Wallis, A.F. et al. (1992) The influence of salmeterol xinafoate on mucosal inflammation in asthma. Am. Rev. Respir. Dis., 145, A418.

    Google Scholar 

  37. Church, M.K. and Hiroi, J. (1987) Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br. J. Pharmacol., 90, 421–9.

    PubMed  CAS  Google Scholar 

  38. Howarth, P.H., Durham, S.R., Lee, T.K. et al. (1985) Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am. Rev. Respir. Dis., 132, 986–92.

    PubMed  CAS  Google Scholar 

  39. Taylor, I.K., O’Shaughnessy, K.M., Choudry, N.B. et al. (1992) A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity and increase in urinary leukotriene E4 excretion. J. Allergy Clin. Immunol., 89, 575–83.

    PubMed  CAS  Google Scholar 

  40. Yukawa, T., Ukena, D., Chanez, P. et al. (1990) Beta-adrenergic receptors on eosinophils: binding and functional studies. Am. Rev. Respir. Dis., 141, 1446–552.

    PubMed  CAS  Google Scholar 

  41. Didier, M., Aussei, C., Ferrua, B. and Fehlman, M. (1987) Regulation of interleukin 2 synthesis by cAMP in human T cells. J. Immunol., 139, 1179–84.

    Google Scholar 

  42. Fuller, R.W., O’Malley, G., Baker, A.J. and MacDermot, J. (1988) Human alveolar macrophage activation: inhibition by forskolin but not β-adrenoceptor stimulation or phosphodiesterase inhibition. Pulm. Pharmacol., 1, 101–6.

    PubMed  CAS  Google Scholar 

  43. Phipps, R.J., Williams, I.P., Richardson, P.S. et al. (1982) Sympathetic drugs stimulate the output of secretory glycoprotein from human bronchi in vitro. Clin. Sci., 63, 23–8.

    PubMed  CAS  Google Scholar 

  44. Knowles, M., Murray, G., Shallal, J. et al. (1984) Bioelectric properties and ion flow across excised human bronchi. J. Appl. Physiol., 56, 868–77.

    PubMed  CAS  Google Scholar 

  45. Devalia, J.L., Sapsford, R.J., Rusznak, C. et al. (1992) The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells in vitro. Pulm. Pharmacol., 5, 257–63.

    PubMed  CAS  Google Scholar 

  46. Leikhauf, G.D., Ueki, I.F. and Nadel, J.A. (1984) Selective autonomie regulation of the viscoelastic properties of submucosal gland secretions from cat trachea. J. Appl. Physiol., 56, 426–30.

    Google Scholar 

  47. Molfino, N.A., Nannini, L.J., Martelli, A.N. and Slutsky, A.S. (1991) Respiratory arrest in near-fatal asthma. N. Engl. J. Med., 324, 285–8.

    PubMed  CAS  Google Scholar 

  48. Crane, J., Pearce, N., Flatt, A. et al. (1989) Prescribed fenoterol and death from asthma in New Zealand 1981–83: case-control study. Lancet, i, 917–22.

    Google Scholar 

  49. Grainger, J., Woodsman, K., Pearce, N. et al. (1991) Prescribed fenoterol and death from asthma in New Zealand 1981–7: a further case control study. Thorax, 46, 105–11.

    PubMed  CAS  Google Scholar 

  50. Spitzer, W.O., Suissa, S., Ernst, P. et al. (1992) The use of β-agonists and the role of death and near-death from asthma. N. Engl. J. Med., 326, 503–6.

    Google Scholar 

  51. Sears, M.R., Taylor, D.R., Print, C.G. et al. (1992) Regular inhaled beta-agonist treatment in bronchial asthma. Lancet, 336, 1391–6.

    Google Scholar 

  52. Van Schayck, C.P., Dompeling, E., van Herwaarden, C.L.A. et al. (1991) Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. Br. Med. J., 303, 1426–31.

    Google Scholar 

  53. Kraan, J., Koeter, G.H., Van der Mark, T.W. et al. (1985) Changes in bronchial hyperractivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J. Allergy Clin. Immunol., 76, 628–36.

    PubMed  CAS  Google Scholar 

  54. Kerrebijn, K.F., Von Essen-Zandvliet, E.E.M. and Neijens, H.J. (1987) Effect of long-term treatment with inhaled corticosteroids and beta-agonists on bronchial responsiveness in asthmatic children. J. Allergy Clin. Immunol., 79, 653–9.

    PubMed  CAS  Google Scholar 

  55. Van Schayck, C.P., Graafsma, S.J., Visch, M.B. et al. (1990) Increased bronchial hyper-responsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbuterol. J. Allergy Clin. Immunol., 86, 793–800.

    PubMed  Google Scholar 

  56. Tattersfield, A.E. (1985) Tolerance to beta-agonists. Clin. Resp. Physiol., 21, 1–5S.

    Google Scholar 

  57. Hasegawa, M. and Townley, R.G. (1984) Differences between lung and spleen susceptibility to desensitization to terbutaline. J. Allergy Clin. Immunol., 71, 230–8.

    Google Scholar 

  58. Guillot, C., Fornaris, M., Badger, M. and Orehek, J. (1984) Spontaneous and provoked resistance to isoproterenol in isolated human bronchi. J. Allergy Clin. Immunol., 74, 713–8.

    PubMed  CAS  Google Scholar 

  59. Nishikawa, M., Mak, J.C.W., Shirasaki, H. et al. (1994) Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary β-adrenergic receptors in guinea pigs. Am. J. Respir. Cell. Mol. Biol., 10, 91–9.

    PubMed  CAS  Google Scholar 

  60. O’Connor, B.J., Aikman, S.L. and Barnes, P.J. (1992) Tolerance to the non-bronchodilator effects of inhaled β2-agonists. N. Engl. J. Med., 327, 1204–8.

    PubMed  Google Scholar 

  61. Ullman, A., Hedner, J. and Svedmyr, N. (1990) Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am. Rev. Respir. Dis., 142, 571–5.

    PubMed  CAS  Google Scholar 

  62. Kesten, S., Chapman, K.R., Broder, I. et al. (1991) A 3 month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am. Rev. Respir. Dis., 144, 622–5.

    PubMed  CAS  Google Scholar 

  63. Cheung, D., Timmers, M.C., Zwinderman, A.H. et al. (1992) The prolonged effects of salmeterol on airway hyperresponsiveness in asthma. N. Engl. J. Med., 327, 1198–1203.

    PubMed  CAS  Google Scholar 

  64. Collins, S., Caron, M.G. and Lefkowitz, R.J. (1992) From ligand binding to gene expression: new insights into the regulation of G-protein-coupled receptors. Trends Pharmacol. Sci., 17, 37–9.

    CAS  Google Scholar 

  65. Hadcock, J.R., Wang, H.Y. and Malbon, C.C. (1989) Agonist-induced destabilization of β-adrenergic receptor mRNA: attenuation of glucocorticoid-induced up-regulation of β-adrenergic receptors. J. Biol. Chem., 264, 19928–33.

    PubMed  CAS  Google Scholar 

  66. Davis, A.O. and Lefkowitz, R.J. (1984) Regulation of beta adrenergic receptors by steroid hormones, Ann. Rev. Physiol., 46, 119–30.

    Google Scholar 

  67. Mak, J.C.W., Adcock, I. and Barnes, P.J. (1992) Dexamethasone increases β2-adrenoceptor gene expression in human lung. Am. Rev. Respir. Dis., 145, A834.

    Google Scholar 

  68. Barnes, P.J. (1987) Cholinergic control of airway smooth muscle. Am. Rev. Respir. Dis., 136, S42–S45.

    PubMed  CAS  Google Scholar 

  69. Widdicombe, J.G., Karlsson, J-A. and Barnes, P.J. 1991. Cholinergic mechanisms in bronchial hyperresponsiveness and asthma, in Asthma: Its Pathology and Treatment, (eds. Kaliner, M.A., Barnes, P.J. and Persson, C.G.A.), Marcel Dekker, New York, pp. 327–56.

    Google Scholar 

  70. Barnes, P.J., Basbaum, C.B. and Nadel, J.A. (1983) Autoradiographic localization of autonomic receptors in airway smooth muscle: marked differences between large and small airways. Am. Rev. Respir. Dis., 127, 758–62.

    PubMed  CAS  Google Scholar 

  71. Mak, J.C.W. and Barnes, P.J. (1990) Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am. Rev. Respir. Dis., 141, 1559–68.

    PubMed  CAS  Google Scholar 

  72. Ingram, R.H. Jr, Wellman, J.J., McFadden, E.R. Jr. et al. (1977) Relative contribution of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol. J. Clin. Invest., 59, 696–703.

    PubMed  CAS  Google Scholar 

  73. Nadel, J.A. and Barnes, P.J. (1984) Autonomic regulation of the airways. Ann. Rev. Med., 35, 451–67.

    PubMed  CAS  Google Scholar 

  74. Karlsson, J-A., Sant’Ambrogio, G. and Widdicombe, J.G. (1988) Afferent neural pathways in cough and reflex bronchoconstriction. J. Appl. Physiol., 65, 1007–23.

    PubMed  CAS  Google Scholar 

  75. Fox, A.J., Barnes, P.J., Urban, L. and Dray, A. (1993) An in vitro study of the properties of single vagal afferents innervating guinea-pig airways. J. Physiol. (Land.), 469, 21–35.

    CAS  Google Scholar 

  76. Herve, P., Denjean, A., Jian, R. et al. (1986) Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am. Rev. Respir. Dis., 139, 986–9.

    Google Scholar 

  77. Gross, N.J., Co, E. and Skorodin, M.S. (1989) Cholinergic bronchomotor tone in COPD: estimates of its amount in comparison with that in normal subjects. Chest, 96, 984–7.

    PubMed  CAS  Google Scholar 

  78. Patrick, D.M., Dales, R.E., Stark, R.M. et al. (1990) Severe exacerbations of COPD and asthma: incremental benefit of adding ipratropium to usual therapy. Chest, 98, 295–7.

    PubMed  CAS  Google Scholar 

  79. Lefcoe, N.M., Toogood, J.H., Blennerhassett, G. et al. (1982) The addition of an aerosol anti-cholinergic to an oral beta agonist plus theophylline in asthma and bronchitis. Chest, 82, 300–5.

    PubMed  CAS  Google Scholar 

  80. Gross, N.J. and Skorodin, M.S. (1984) Anticholinergic, antimuscarinic bronchodilators. Am. Rev. Respir. Dis., 129, 856–70.

    PubMed  CAS  Google Scholar 

  81. Chapman, K.R. (1990) The role of anticholinergic bronchodilators in adult asthma and COPD. Lung, 168 (Suppl.), 295–303.

    PubMed  Google Scholar 

  82. Gross, N.J. and Skorodin, M.S. (1984) Role of the parasympathetic system in airway obstruction due to emphysema. N. Engl. J. Med., 311, 321–5.

    Google Scholar 

  83. Braun, S.R., McKenzie, W.N. Copeland, C. et al. (1989) A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch. Intern. Med., 149, 544–7.

    PubMed  CAS  Google Scholar 

  84. Rogers, D.F., Aursudkij, B., and Barnes, P.J. (1989) Effects of tachykinins on mucus secretion on human bronchi in vitro. Eur. J. Pharmacol., 174, 283–6.

    PubMed  CAS  Google Scholar 

  85. Tokuyama, K., Kuo, H-P., Rohde, J.A.L. et al. (1990) Neural control of goblet cell secretion in guinea pig airways. Am. J. Physiol., 259, L108–L115.

    PubMed  CAS  Google Scholar 

  86. Kuo, H-P., Barnes, P.J. and Rogers, D.F. (1992) Cigarette smoke induced goblet cell secretion: dose-dependent differential nerve activation. Am. J. Physiol., 7, L161–L167.

    Google Scholar 

  87. Connolly, C.K. (1979) Diurnal rhythms in airway obstruction. Br. J. Dis. Chest, 73, 357–66.

    PubMed  CAS  Google Scholar 

  88. Coe, C.I. and Barnes, P.J. (1986) Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest, 90, 485–8.

    PubMed  CAS  Google Scholar 

  89. Morrison, J.F.J., Pearson, S.B. and Dean, H.G. (1988) Parasympathetic nervous system in nocturnal asthma. Br. Med. J., 296, 1427–9.

    CAS  Google Scholar 

  90. Barnes, P.J. (1987) Muscarinic receptors in lung. Postgrad. Med. J., 63 (Suppl.), 13–19.

    PubMed  CAS  Google Scholar 

  91. Barnes, P.J. (1990) Muscarinic receptors in airways: recent developments. J. Appl. Physiol., 68, 1777–85.

    PubMed  CAS  Google Scholar 

  92. Hulme, E.C., Birdsall, N.J.M. and Buckley, N.J. (1990) Muscarinic receptor subtypes. Ann. Rev. Pharmacol., 30, 633–73.

    CAS  Google Scholar 

  93. Chilvers, E.R., Challiss, R.A.J., Barnes P.J. and Nahorski S.R. (1989) Mass changes of inositol (1,4,5)trisphosphate in trachealis muscle following agonist stimulation. Eur. J. Pharmacol., 164, 587–90.

    PubMed  CAS  Google Scholar 

  94. Chilvers, E.R., Batty, I.H., Challiss, R.A.J. et al. (1990) Formation of inositol polyphosphates in airway smooth muscle after muscarinic receptor stimulation. J. Pharmacol. Exp. Ther., 252, 786–91.

    PubMed  CAS  Google Scholar 

  95. Roffel, A.F., Elzinga, C.R.S. and Zaagsma, J. (1990) Muscarinic M3-receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm. Pharmacol., 3, 47–51.

    PubMed  CAS  Google Scholar 

  96. Jones, C.A., Madison, J.M., Tom-Moy, M. and Brown, J.K. (1987) Muscarinic cholinergic inhibition of adenylate cyclase in airway smooth muscle. Am. J. Physiol., 253, C90–C104.

    Google Scholar 

  97. Ueki, I., German, V. and Nadel, J. (1980) Micropipette measurement of airway sub-mucosal gland secretion: autonomic effects. Am. Rev. Respir. Dis., 121, 351–7.

    PubMed  CAS  Google Scholar 

  98. Minette, P.A. and Barnes, P.J. (1990) Muscarinic receptor subtypes in airways: function and clinical significance. Am. Rev. Respir. Dis., 141, S162–S165.

    PubMed  CAS  Google Scholar 

  99. Hammer, R., Berrie, C.P., Birdsall, N.J.M. et al. (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature, 283, 90–2.

    PubMed  CAS  Google Scholar 

  100. Bloom, J.W., Baumgartener-Folkerts, C., Palmer, J.D. et al. (1988) A muscarinic receptor subtype modulates vagally stimulated bronchial contraction. J. Appl. Physiol., 65, 2144–50.

    PubMed  CAS  Google Scholar 

  101. Lammers, J.-W.J., Minette, P., McCusker, M. and Barnes, P.J. (1989) The role of pirenzepine-sensitive (M1) muscarinic receptors in vagally mediated bronchoconstriction in humans. Am. Rev. Respir. Dis., 139, 446–9.

    PubMed  CAS  Google Scholar 

  102. Ashe, J.H. and Yarosh, C.A. (1984) Differential and selective antagonism of the slow-inhibitory postsynaptic potential and slow-excitatory postsynaptic potential by gallanin and pirenzepine in the superior cervical ganglion of the rabbit. Neuropharmacology, 23, 1321–9.

    PubMed  CAS  Google Scholar 

  103. Ukena, D., Wehinger, C., Engelstatter, R. et al. (1993) The muscarinic M1-receptor selective antagonist telenzepine has no bronchodilator effects in patients with chronic obstructive airways disease. Eur. Resp. J., 6, 378–82.

    CAS  Google Scholar 

  104. Mak, J.C.W. and Barnes P.J. (1989) Muscarinic receptor subtypes in human and guinea pig lung. Eur. J. Pharmacol., 164, 223–30.

    PubMed  CAS  Google Scholar 

  105. Mak, J.C.W., Baraniuk J.N. and Barnes P.J. (1992) Localization of muscarinic receptor subtype messenger RNAs in human lung. Am. J. Resp. Cell. Mol. Biol., 7, 344–8.

    CAS  Google Scholar 

  106. Lazareno, S., Buckley, N.J. and Roberts, F.F. (1990) Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart and NG 108-15 cells. Mol. Pharmacol., 38, 805–15.

    PubMed  CAS  Google Scholar 

  107. Kilbinger, H. and Wessler, T. (1980) Inhibition by acetylcholine of the stimulation-evoked release of [3H]acetylcholine from guinea-pig myenteric plexus. Neurosci., 5, 1331–40.

    CAS  Google Scholar 

  108. Fryer, A.D. and Maclagan, J. (1984) Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br. J. Pharmacol., 83, 973–8.

    PubMed  CAS  Google Scholar 

  109. Minette, P.A. and Barnes, P.J. (1988) Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea-pig airways. J. Appl. Physiol., 64, 2532–7.

    PubMed  CAS  Google Scholar 

  110. Watson, N., Barnes, P.J. and Maclagan, J. (1992) Action of methoctramine, a muscarinic M2-receptor antagonist, on muscarinic and nicotine cholinoceptors in guinea pig airways in vivo and in vitro. Br. J. Pharmacol., 105, 107–12.

    PubMed  CAS  Google Scholar 

  111. Blaber, L.C., Fryer, A.D. and Maclagan, J. (1985) Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle. Br. J. Pharmacol., 86, 723–8.

    PubMed  CAS  Google Scholar 

  112. Aas, P. and Maclagan, J. (1990) Evidence for prejunctional M2 muscarinic receptors in pulmonary cholinergic nerves in the rat. Br. J. Pharmacol., 101, 73–6.

    PubMed  CAS  Google Scholar 

  113. Ito, Y. and Yoshitomi, T. (1988) Autoregulation of acetylcholine release from vagus nerve terminals through activation of muscarinic receptors in the dog trachea. Br. J. Pharmacol., 93, 636–46.

    PubMed  CAS  Google Scholar 

  114. Kilbinger, H., Schoreider, R., Siefken, H. et al. (1991) Characterization of prejunctional muscarinic autoreceptors in guinea pig trachea. Br. J. Pharmacol., 103, 1757–63.

    PubMed  CAS  Google Scholar 

  115. Del Monte, M., Omini, C. and Subissi, A. (1990) Mechanism of the potentiation of neurally-induced bronchoconstriction by gallamine in the guinea pig. Br. J. Pharmacol., 99, 582–8.

    PubMed  Google Scholar 

  116. Minette, P.A.H., Lammers, J., Dixon, C.M.S. et al. (1989). A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J. Appl. Physiol., 67, 2461–5.

    PubMed  CAS  Google Scholar 

  117. Ayala, L.E. and Ahmed, T. (1991) Is there a loss of a protective muscarinic receptor mechanism in asthma? Chest, 96, 1285–91.

    Google Scholar 

  118. Barnes, P.J. (1989) Muscarinic autoreceptors in airways: their possible role in airway disease. Chest, 96, 1220–1.

    PubMed  CAS  Google Scholar 

  119. Barnes, P.J. (1989) Muscarinic receptor subtypes: implications for lung disease. Thorax, 44, 161–7.

    PubMed  CAS  Google Scholar 

  120. Ind, P.W., Dixon, C.M.S., Fuller, R.W. and Barnes, P.J. (1989) Anticholinergic blockade of beta-blocker induced bronchoconstriction. Am. Rev. Respir. Dis., 139, 1390–4.

    PubMed  CAS  Google Scholar 

  121. Fryer, A.D. and Jacoby, D.B. (1991) Para-influenza virus infection damages inhibitory M2-muscarinic receptors on pulmonary parasympathetic nerves in the guinea pig. Br. J. Pharmacol., 102, 267–71.

    PubMed  CAS  Google Scholar 

  122. Gies, J-P. and Landry, Y. (1988) Sialic acid is selectively involved in the interaction of agonists at M2 muscarinic acetylcholine receptors. Biochem. Biophys. Res. Commun., 150, 673–80.

    PubMed  CAS  Google Scholar 

  123. Jacoby, D.B., Gleich, G.J. and Fryer, A.D. (1992) Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. Am. Rev. Respir. Dis., 145, A436.

    Google Scholar 

  124. Roffel, A.F., Elzinga, C.R.S., van Amsterdam, R.G.M. et al. (1988) Muscarinic M2-receptors in bovine tracheal smooth muscle: discrepancies between binding and function. Eur. J. Pharmacol., 153, 73–82.

    PubMed  CAS  Google Scholar 

  125. Yang, C.M., Chow, S-P. and Sung, T-C. (1991) Muscarinic receptor subtypes coupled to generation of different second messengers in isolated tracheal smooth muscle cells. Br. J. Pharmacol., 104, 613–8.

    PubMed  CAS  Google Scholar 

  126. Fernandes, L.B., Fryer, A.D. and Hirschman, C.A. (1992) M2 muscarinic receptors inhibit isoproterenol-induced relaxation of canine airway smooth muscle. J. Pharmacol. Exp. Ther., 262, 119–26.

    PubMed  CAS  Google Scholar 

  127. Gater, P., Alabaster, V.A. and Piper, I. (1989) Characterisation of the muscarinic receptor subtype mediating mucus secretion in the cat trachea in vitro. Pulm. Pharmacol., 2, 87–92.

    PubMed  CAS  Google Scholar 

  128. Yang, C.M., Farley, J.M. and Dwyer, T.M. (1988) Muscarinic stimulation of submucosal glands in swine trachea. J. Appl. Physiol., 64, 200–9.

    PubMed  CAS  Google Scholar 

  129. D’Agostino, G., Chiari, M.C., Grana, E. and Kilbinger, H. (1990) Muscarinic inhibition of acetylcholine release from a novel in vitro preparation of the guinea pig trachea. Naunyn-Schmiedeberg’s Arch. Pharmacol., 342, 141–5.

    Google Scholar 

  130. Connolly, C.K. (1982) Adverse reaction to ipratropium bromide. Br. Med. J., 285, 934–5.

    CAS  Google Scholar 

  131. Kurtenbach, E., Curtis, C.A.M., Pedder, E.K. et al. (1990) Muscarinic acetylcholine receptors. J. Biol. Chem., 265, 13702–8.

    PubMed  CAS  Google Scholar 

  132. Maesen, F.P.V., Smeets, J.J., Costongs, M.A.L. et al. (1992) B679 BR. A new long-acting antimuscarinic bronchodilator. Eur. Resp. J., 5 (Suppl. 15), 211S.

    Google Scholar 

  133. Taylor, D.R., Buick, B., Kinney, C. et al. (1985) The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible airflow obstruction. Am. Rev. Respir. Dis., 131, 747–51.

    PubMed  CAS  Google Scholar 

  134. Murciano, D., Avclair, M-H., Pariente, R. and Aubier, M. (1989) a randomized controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N. Engl. J. Med., 320, 1521–5.

    PubMed  CAS  Google Scholar 

  135. Chrystyn, H., Mulley, B.A. and Peake, M.D. (1988) Dose response relation to oral theophylline in severe chronic obstructive airway disease. Br. Med. J., 297, 1506–10.

    CAS  Google Scholar 

  136. Beavo, J.A. and Reifsnyder, D.H. (1990) Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 150–5.

    PubMed  CAS  Google Scholar 

  137. Nicholson, C.D., Challiss, R.A.J. and Shahid, M. (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci., 12, 19–27.

    PubMed  CAS  Google Scholar 

  138. Torphy, T.J. and Undem, R.J. (1991) Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax, 46, 499–503.

    Google Scholar 

  139. Giembycz, M.A. (1992) Could selective cyclic nucleotide phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? Biochem. Pharmacol., 43, 2041–51.

    PubMed  CAS  Google Scholar 

  140. Bachelet, M., Vincent, D., Havet, N. et al. (1991) Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma. J. Allergy Clin. Immunol., 88, 322–8.

    PubMed  CAS  Google Scholar 

  141. Cushley, M.J., Tattersfield, A.E. and Holgate, S.T. (1984) Adenosine-induced bronchoconstriction in asthma: antagonism by inhaled theophylline. Am. Rev. Respir. Dis., 129, 380–1.

    PubMed  CAS  Google Scholar 

  142. Persson, C.G.A. (1986) Development of safer xanthine drugs for the treatment of obstructive airways disease. J. Allergy Clin. Immunol., 78, 817–24.

    PubMed  CAS  Google Scholar 

  143. Cushley, M.J. and Holgate, S.T. (1985) Bronchodilator actions of xanthine derivatives administered by inhalation in asthma. Thorax, 40, 176–9.

    PubMed  CAS  Google Scholar 

  144. Shohat, B., Volovitz, B. and Varsano, I. (1983) Induction of suppressor T cells in asthmatic children by theophylline treatment. Clin. Allergy, 13, 487–93.

    PubMed  CAS  Google Scholar 

  145. Guillou, P.J., Ramsden, C., Kerr, M. et al. (1984) A prospective controlled clinical trial of aminophylline as an adjunct immunosuppressive agent. Transpl. Proc., 16, 1218–20.

    CAS  Google Scholar 

  146. Persson, C.G.A. (1988) Xanthines as airway anti-inflammatory drugs. J. Allergy Clin. Immunol., 81, 615–7.

    PubMed  CAS  Google Scholar 

  147. Pauwels, R., van Revterghem, D., van der Straeten, M. et al. (1985) The effect of theophylline and enprophylline on allergen-induced bronchoconstriction. J. Allergy Clin. Immunol., 76, 583–90.

    PubMed  CAS  Google Scholar 

  148. Fink, G., Mittelman, M., Shohat, B. and Spitzer, S.A. (1987) Theophylline-induced alterations in cellular immunity in asthmatic patients. Clin. Allergy, 17, 313–6.

    PubMed  CAS  Google Scholar 

  149. Yukawa, T., Kroegel, C., Dent, G. et al. (1989) Effect of theophylline and adenosine on eosinophil function. Am. Rev. Respir. Dis., 140, 327–33.

    PubMed  CAS  Google Scholar 

  150. Cockcroft, D.W., Murdock, K.Y., Gore, B.P. et al. (1991) Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine. J. Allergy Clin. Immunol., 83, 913–20.

    Google Scholar 

  151. Dutoit, J.I., Salome, C.M. and Woolcock, A.J. (1987) Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma, but oral theophylline does not. Am. Rev. Respir. Dis., 136, 1174–8.

    PubMed  CAS  Google Scholar 

  152. Aubus, P., Cosso, B., Godard, P. et al. (1984) Decreased suppressor cell activity of alveolar macrophages in bronchial asthma. Am. Rev. Respir. Dis., 130, 875–8.

    Google Scholar 

  153. Moxham, J. (1988) Aminophylline and the respiratory muscles: an alternative view. Clin. Chest Med., 2, 325–40.

    Google Scholar 

  154. Weinburger, M. (1984) The pharmacology and therapeutic use of theophylline. J. Allergy Clin. Immunol., 73, 525–40.

    Google Scholar 

  155. Black, J.L., Armour, C.L., Johnson, P.R.A. et al. (1990) The action of a potassium channel activator BRL 38227 (lemakalim) on human airway smooth muscle. Am. Rev. Respir. Dis., 142, 1384–9.

    PubMed  CAS  Google Scholar 

  156. Black, J.L. and Barnes, P.J. (1990) Potassium channels and airway function: new therapeutic approaches. Thorax, 45, 213–8.

    PubMed  CAS  Google Scholar 

  157. Williams, A.J., Lee, T.H., Cochrane, G.M. et al. (1990) Attenuation of nocturnal asthma by cromakalim. Lancet, 336, 334–6.

    PubMed  CAS  Google Scholar 

  158. Kidney, J.C., Fuller, R.W., Wordsell, Y.M. et al. (1993) Effect of oral potassium channel activator BFL 38227 on airway function and responsiveness in asthmatic patients: comparison with salbutamol. Thorax, 48, 130–4.

    PubMed  CAS  Google Scholar 

  159. Crawley, D., Liu, S.F., Evans, T.W. et al. (1992) Role of potassium channels in relaxations of human small pulmonary arteries. Am. Rev. Respir. Dis., 145, A228.

    Google Scholar 

  160. Belvisi, M.G., Miura, M., Peters, M.J. et al. (1992) Effect of isoenzyme-selective cyclic nucleotide phosphodiesterase inhibitors on human tracheal smooth muscle tone. Br. J. Pharmacol., 107, 53P.

    Google Scholar 

  161. Dent, G., Giembycz, M.A., Rabe, K.F. and Barnes, P.J. (1991) Inhibition of eosinophil cyclic nucleotide PDF activity and opsonized zymosan-stimulated respiratory burst by ‘type IV’ PDE inhibitors. Br. J. Pharmacol., 103, 1339–46.

    PubMed  CAS  Google Scholar 

  162. Sanjar, S., Aoki, S., Kristersson, A. et al. (1990) Antigen challenge induces pulmonary eosinophil accumulation and airway hyper-reactivity in sensitized guinea pigs: the effect of anti-asthma drugs. Br. J. Pharmacol., 99, 679–86.

    PubMed  CAS  Google Scholar 

  163. Gruetter, C.A., Childers, C.C., Bosserman, M.K. et al. (1989) Comparison of relaxation induced by glyceryl trinitate, isosorbide dinitrate and sodium nitroprusside in bovine airways. Am. Rev. Respir. Dis., 139, 1192–7.

    PubMed  CAS  Google Scholar 

  164. Belvisi, M.G., Stretton, C.D. and Barnes, P.J. (1992) Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways. Eur. J. Pharmacol., 210, 221–2.

    PubMed  CAS  Google Scholar 

  165. Hulks, G., Jardine, A.G., Connell, J.M.C. and Thomson, N.C. (1989) Bronchodilator effect of atrial natriuretic peptide in asthma. Br. Med. J., 292, 1081–2.

    Google Scholar 

  166. Cookson, W.O.C.M. (1987) Bronchodilator action of the antihistamine terfenadine. Br. J. Clin. Pharmacol., 24, 120–1.

    PubMed  CAS  Google Scholar 

  167. Hui, K.P. and Barnes, N.C. (1991) Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Lancet, 337, 1062–3.

    PubMed  CAS  Google Scholar 

  168. Barnes, P.J., Baraniuk, J. and Belvisi, M.G. (1991) Neuropeptides in the respiratory tract. Am. Rev. Respir. Dis., 144, 1187–98, 1391-9.

    PubMed  CAS  Google Scholar 

  169. Watling, K.J. (1992) Non peptide antagonists herald a new era in tachykinin research. Trends Pharmacol. Sci., 13, 266–9.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. J. Barnes
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Aintree Chest Clinic, Regional Thoracic Unit, Fazakerley Hospital, Longmoor Lane, Liverpool, L9 7AL, UK

    P. M. A. Calverley (Consultant Physician, Senior Fellow) (Consultant Physician, Senior Fellow)

  2. Department of Medicine, University of Liverpool, UK

    P. M. A. Calverley (Consultant Physician, Senior Fellow) (Consultant Physician, Senior Fellow)

  3. Department of Medicine, (Respiratory Division), Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK

    N. B. Pride (Consultant Physician, Professor of Respiratory Medicine) (Consultant Physician, Professor of Respiratory Medicine)

  4. Royal Postgraduate Medical School, London, UK

    N. B. Pride (Consultant Physician, Professor of Respiratory Medicine) (Consultant Physician, Professor of Respiratory Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Barnes, P.J. (1995). Bronchodilators: Basic Pharmacology. In: Calverley, P.M.A., Pride, N.B. (eds) Chronic Obstructive Pulmonary Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-4525-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-4525-9_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-46450-8

  • Online ISBN: 978-1-4899-4525-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation